Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
06/2012
06/28/2012WO2012030166A3 Iron oxide nanocapsule, method of manufacturing the same, and mri contrast agent using the same
06/28/2012WO2012030134A3 Iron oxide nanocapsules, method of manufacturing the same, and mri contrast agent using the same
06/28/2012WO2011133685A9 Nanoparticle targeting to ischemia for imaging and therapy
06/28/2012WO2011101418A3 Infiltration solution for treating an enamel lesion
06/28/2012US20120167236 Method of predicting a behavior of one or more drugs
06/28/2012US20120165650 Her2 binders
06/28/2012US20120165646 Composite particle, contrast agent for photoacoustic imaging, and photoacoustic imaging method
06/28/2012US20120164078 Methods of using sustained release aminopyridine compositions
06/28/2012US20120164077 Predictive assays for cell transplantation efficacy and methods of using human neuropotentiating cells
06/28/2012US20120164076 Methods of treatment using thymus-derived compositions
06/28/2012US20120164075 Endoxifen methods and compositions in the treatment of mammalian diseases
06/28/2012US20120164074 Methods of diagnosing, preventing and treating cancer metastasis
06/28/2012US20120164073 Stable nanoparticles, nanoparticle-based imaging systems, nanoparticle-based assays, and in vivo assays for screening biocompatibility and toxicity of nanoparticles
06/28/2012US20120164072 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
06/28/2012US20120164071 Compositions and Methods Comprising Phosphatidylethanolamine-Binding Peptide Derivatives
06/28/2012US20120164069 Compositions and methods for surface abrasion with frozen particles
06/28/2012US20120164068 Immuno-conjugates and methods for producing them
06/28/2012US20120164066 Antigen-binding proteins comprising recombinant protein scaffolds
06/27/2012EP2469285A1 Water soluble metal and semiconductor nanoparticle complexes
06/27/2012EP2468305A1 Use of a fluorinated polymer as a contrast agent in solid state 19F magnetic resonance imaging (MRI), scaffold comprising said polymer and use thereof.
06/27/2012EP2468175A1 Method for managing the risk of liver injury in patients receiving treatment with dronedarone
06/27/2012EP2467169A1 In vivo screening assays
06/27/2012EP2467168A1 Peptidic conjugates comprising polyhistidine sequence and free cysteine and their uses in imaging
06/27/2012EP2194866B1 Device, gas mixture and method for lung diagnosis
06/27/2012CN102517330A Adenovirus vector and its application in preparing HCV cell and mouse models
06/27/2012CN102517021A Upconversion nano-material for lymphatic vessel identification and preparation method thereof
06/27/2012CN102516398A Method for constructing anti-mammitis transgenic mouse model and special vector for method
06/27/2012CN102516391A Neuropilin-1 ligand polypeptide-polyethylene glycol-phospholipid composite, its active targeting liposome vector system and preparation method thereof
06/27/2012CN102516383A Novel mite allergen
06/27/2012CN102516361A NRP-1 ligand polypeptide-polyethylene glycol-phosphatide compound, active targeting liposome drug delivery system mediated thereby and preparation method thereof
06/27/2012CN102516116A Low-osmotic-pressure triiodo-benzene compound contrast agent
06/27/2012CN102513046A Magnetic polyelectrolyte microcapsule and its preparation method
06/27/2012CN102512696A Medical ultrasonic couplant and preparation method thereof
06/27/2012CN102512695A Traditional Chinese medicinal capsule convenient for examining infantile congenital hypertrophic pyloric stenosis
06/27/2012CN102512657A Pentagastrin liquid injection and preparation method thereof
06/27/2012CN101899161B Preparation method of polyethylene glycol-modified ferric oxide nano-probe
06/27/2012CN101818128B Superparamagnetic iron oxide labeled human pancreas cancer cell strain as well as labeling method and application thereof
06/27/2012CN101716353B Folic acid composite used for imageology diagnosis of tumor and lymphatic metastasis tumor
06/27/2012CN101341119B Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure
06/26/2012US8207293 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest
06/26/2012US8206685 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to treat or prevent Cancer
06/26/2012US8206636 Stent fabrication via tubular casting processes
06/26/2012US8206635 Stent fabrication via tubular casting processes
06/26/2012CA2432474C Fibrin binding polypeptides useful inter alia in medical imaging processes
06/21/2012WO2012081893A2 Novel 3-indolinone derivative and composition having same
06/21/2012WO2012080705A1 Imaging agents
06/21/2012WO2012080290A1 Nanoparticle composition and associated methods thereof
06/21/2012WO2012080279A1 Radiopaque iodinated products intended for use medical imaging and their methods of preparation
06/21/2012WO2012079989A1 Compounds for diagnosing diseases associated with the expression of muc5ac
06/21/2012WO2012061113A3 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
06/21/2012US20120159655 Methods using axl as a biomarker of epithelial-to-mesenchymal transition
06/21/2012US20120157824 Mri and optical assays for proteases
06/21/2012US20120156142 Diagnostic agent composition and associated methods thereof
06/21/2012US20120156141 Nanoparticle composition and associated methods thereof
06/21/2012US20120156140 Fluorescent compounds
06/21/2012US20120156139 Isotopically labeled neurochemical agents and uses therof for diagnosing conditions and disorders
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/21/2012US20120156137 Composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them
06/21/2012US20120156136 Method and device for identifying a material likely to generate eye or skin discomfort, tingling, or irritation
06/21/2012US20120156135 Particles with multiple functionalized surface domains
06/21/2012US20120156134 Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
06/21/2012US20120156132 Targeting agent to newly formed blood vessels
06/21/2012US20120156131 Diagnosis and treatment of tumors
06/21/2012DE102010055299A1 Biologisch abbaubare Kontrastmittel Biodegradable contrast agent
06/21/2012CA2821856A1 Imaging agents
06/21/2012CA2819795A1 Nanoparticle composition and associated methods thereof
06/20/2012EP2464386A1 Ultrasound couplant
06/20/2012EP1546203B1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
06/20/2012EP1390016B2 Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
06/20/2012CN102504603A Conjugate of polymer and biological stain and preparation method and application thereof
06/20/2012CN102504015A Cardiovascular targeted small peptide MI-1 and application thereof
06/20/2012CN102499177A Application of IgAN glomerular sclerosis rat model
06/20/2012CN102499135A Zebra fish vascular injury model for screening vascular injury resisting medicament as well as building method and application thereof
06/19/2012US8202974 Synthetic RNA-based agonists of TLR7
06/19/2012US8202511 Contrast agents
06/19/2012US8202510 Biomarkers for amyotrophic lateral sclerosis
06/19/2012CA2478012C Internalizing anti-cd74 antibodies and methods of use
06/14/2012WO2012078813A2 Novel modulators and methods of use
06/14/2012WO2012078647A2 Chemical composition to detect and treat amyloid in a patient's brain and retina
06/14/2012WO2012077811A1 Galectin 9-secreting cell, production method for same, and application for same
06/14/2012WO2012076191A1 Aptamer labeled with f-19 nucleus for targeted molecular imaging by mri
06/14/2012WO2012075602A1 Ultrasonic microbubble target-locating controlled releasing drug/gene device and target transfer method
06/14/2012WO2012075533A1 Multifunctional nanoparticles
06/14/2012WO2012050896A3 Protease selective supramolecular assemblies
06/14/2012WO2012018240A9 Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same
06/14/2012US20120151609 Genetically Modified Rat Models for Pain
06/14/2012US20120149890 Polynucleotides Encoding Thymidine Kinase Mutants
06/14/2012US20120148502 Carbohydrate-Mediated Tumor Targeting
06/14/2012US20120148501 Radiological image enhancement with tantalum clusters
06/14/2012US20120148500 Use of a Fluorinated Polymer as a Contrast Agent in Solid State 19F Magnetic Resonance Imaging (MRI), Scaffold Comprising Said Polymer and Use Thereof
06/14/2012US20120148499 Peptides and aptamers for targeting of neuron or nerves
06/14/2012US20120148498 Compositions and Methods for the Systemic Treatment of Arthritis
06/14/2012US20120148497 Methods of using field-derived colonies of insects selected for decreased susceptibility to plants expressing insecticidal toxins
06/14/2012US20120148496 Method of Altering Reaction Time
06/14/2012US20120148495 Methods for treating nicotinic acetylcholine receptor associated diseases
06/14/2012US20120148494 Isotopically-labeled benzofuran compounds as imaging agents for amyloidogenic proteins
06/14/2012US20120148493 Composite Materials Loaded with Therapeutic and Diagnostic Agents Comprising Polymer Nanoparticles and Polymer Fibers
06/14/2012US20120148490 Anti-ngf compositions and use thereof
06/14/2012CA2820754A1 Aptamer labelled with f-19 nucleus for targeted molecular imaging by mri
06/14/2012CA2820642A1 Galectin-9-secreting cell, and production method and use of the same
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 354